Meeting
2016 Palliative and Supportive Care in Oncology Symposium
Clinical and health care setting of patients admitted at Pain Control Center Hospice of Solofra: A feasibility model of end-of-life care in the Avellino province of Italy.
Authors
Geppino Genua
Pain Control Center Hospice, Solofra, Italy
Geppino Genua, Carmela Fasano, Luisa M. Rizzo, A. M. Strollo, Elena De Vinco, Vincenzo Landolfi, Elena Altieri, Mario Nicola Vittorio Ferrante, Sergio Canzanella, Giuseppe Servillo, Lucia Genua, Maddalena Zampi, Gaetano D'Onofrio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biologic Basis of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship,Management/Prevention of Symptoms and Treatment Toxicities,Psychosocial and Spiritual Care,Communication in Advanced Cancer
Sub Track
Hospice
Citation
J Clin Oncol 34, 2016 (suppl 26S; abstr 59)
DOI
10.1200/jco.2016.34.26_suppl.59
Abstract #
59
Poster Bd #
E11
Abstract Disclosures
Similar Posters
Poster
2014 Palliative and Supportive Care in Oncology Symposium
Analgesic treatment and pain killer use in patients enrolled at Pain Control Center Hospice of Solofra (Italy).
First Author: Geppino Genua
Poster
2017 Palliative and Supportive Care in Oncology Symposium
Opioid switch and change of route of administration in palliative care cancer patients treated by morphine: Update of French guidelines.
First Author: Philippe Poulain
Poster
2017 Palliative and Supportive Care in Oncology Symposium
Opioid epidemic or pain crisis? Exploring prescription opioid medication utilization for patients with cancer in rural Southwest Virginia.
First Author: Virginia T. LeBaron
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Efficacy and safety of methadone in the treatment of pain in palliative care patients with cancer: The EQUIMETH2 national, randomized, open, phase III study.
First Author: Philippe Poulain